CDC: Confirm fungal diagnosis before prescribing antifungals

The CDC on Thursday urged physicians to be judicious in prescribing topical antifungals in light of the recent detection of antimicrobial-resistant superficial fungal infections in the United States.
The warning accompanied new findings from a CDC review of topical antifungal prescriptions filled by Medicare Part D beneficiaries in 2021, which found that nearly half of the more than 6 million prescriptions were written by just 10% of prescribers.
Commenting on the findings, the CDC encouraged providers — whenever possible — to confirm a fungal diagnosis before prescribing topical

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart
This website uses cookies and asks your personal data to enhance your browsing experience.